Ignite Creation Date:
2025-12-24 @ 10:01 PM
Ignite Modification Date:
2025-12-25 @ 7:38 PM
Study NCT ID:
NCT01239732
Status:
COMPLETED
Last Update Posted:
2016-06-10
First Post:
2010-11-10
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Study of the Addition of Avastin (Bevacizumab) to Carboplatin and Paclitaxel Therapy in Patients With Ovarian Cancer
Sponsor:
Hoffmann-La Roche
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-12
Start Date Type:
None
Primary Completion Date:
2015-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-03
Completion Date Type:
ACTUAL
First Submit Date:
2010-11-10
First Submit QC Date:
None
Study First Post Date:
2010-11-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-03-17
Results First Submit QC Date:
None
Results First Post Date:
2016-06-10
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-05-03
Last Update Post Date:
2016-06-10
Last Update Post Date Type:
ESTIMATED